Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 1Thoracic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Neoplasms 1Neoplasm Metastasis 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 106pembrolizumab 93Pemetrexed 80Cisplatin 68Specimen Handling 44Paclitaxel 38durvalumab 36Nivolumab 36Docetaxel 33Magnetic Resonance Spectroscopy 32osimertinib 28atezolizumab 26Etoposide 22Gemcitabine 21Radiotherapy 19130-nm albumin-bound paclitaxel 18Cetuximab 16amivantamab 14Radiosurgery 14Radiation 12Platinum 12Ipilimumab 12Bevacizumab 12lazertinib 11cemiplimab 11Taxes 11Immunoglobulin G 11Topotecan 10Ramucirumab 10Disulfides 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Panitumumab × Thoracic × 30 days × Clear all
NCT07094204 2026-05-18

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1 Recruiting
364 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡